| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2016 | 2014 | 2013 | 2012 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 117,6 k € | +28.4% | 91,6 k € | +15.8% | 79,1 k € | +45.1% | 54,5 k € | +5.1% | 51,9 k € | +1.9% | 50,9 k € | +24.7% | 40,8 k € | -20.3% | 51,2 k € | -19.8% | 63,9 k € | +6.0% | 60,2 k € | +38.9% | 43,4 k € | |
| EBITDA | 116,9 k € | +29.0% | 90,6 k € | +16.9% | 77,5 k € | +49.2% | 51,9 k € | +2.5% | 50,7 k € | +66.5% | 30,4 k € | -1.3% | 30,8 k € | -39.4% | 50,9 k € | +52.8% | 33,3 k € | +1.8% | 32,7 k € | +13.2% | 28,9 k € | |
| Operating profit | 99,2 k € | +24.1% | 79,9 k € | +10.8% | 72,1 k € | +149.1% | 28,9 k € | +1.4% | 28,6 k € | +242.6% | 8,3 k € | +1.4% | 8,2 k € | -77.5% | 36,6 k € | +120.9% | 16,6 k € | +9.7% | 15,1 k € | -7.6% | 16,3 k € | |
| Profit/loss | 673,2 k € | +17.7% | 572,0 k € | +42.3% | 402,0 k € | +150.0% | 160,8 k € | -37.5% | 257,4 k € | +60.9% | 160,0 k € | +280.3% | 42,1 k € | +85.5% | 22,7 k € | +199.0% | 7,6 k € | +55.5% | 4,9 k € | -34.2% | 7,4 k € | |
| Equity | 1,5 M € | +24.8% | 1,2 M € | +79.2% | 659,4 k € | +129.4% | 287,4 k € | +127.1% | 126,6 k € | +263.3% | 34,8 k € | -73.7% | 132,6 k € | +112.4% | 62,4 k € | +93.4% | 32,3 k € | +30.7% | 24,7 k € | +24.6% | 19,8 k € | |
| Total assets | 1,7 M € | +30.8% | 1,3 M € | +74.0% | 726,5 k € | +129.9% | 316,0 k € | -0.6% | 317,9 k € | +0.6% | 316,0 k € | +5.7% | 298,9 k € | +52.5% | 196,0 k € | +51.8% | 129,1 k € | -20.5% | 162,4 k € | +10.8% | 146,5 k € | |
| Cash | 1,2 M € | +25.5% | 948,3 k € | +97.2% | 480,8 k € | +79.8% | 267,4 k € | +95.4% | 136,9 k € | +156.0% | 53,5 k € | -72.9% | 197,6 k € | +99.3% | 99,1 k € | — | 50,8 k € | +148.6% | 20,5 k € | |||
| Debts | 179,1 k € | +116.3% | 82,8 k € | +23.4% | 67,1 k € | +134.7% | 28,6 k € | -85.1% | 191,3 k € | -31.9% | 281,2 k € | +69.1% | 166,3 k € | +24.9% | 133,2 k € | +37.6% | 96,8 k € | -29.7% | 137,7 k € | +8.7% | 126,7 k € | |
| Staff | — | — | — | — | — | — | — | — | 0,9 | 1,1 | 0,7 | |||||||||||
Private limited company · Welkenraedt · incorporated on 09/02/2012
Private limited company profitable and well capitalised. Cash position rising (+25.5%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Dr Gregory Ernst is a Private limited company incorporated in 2012. Its main activity is: General medical practice activities. Its registered office is in Welkenraedt.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette